Bionyra Pharma
Bionyra Pharma develops biologic therapies for severe immunological and inflammatory diseases.
$165MSeries A
Role not disclosedSP
Sofinnova Partners
Activity from announced rounds
Activity in this selectionSeries A
- Rounds participated in
- 2
- Confirmed lead rounds
- — 2 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $177.8M 2 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
2 in this selectionBrightHeart
BrightHeart develops AI software for prenatal ultrasound and fetal-heart screening.
€11MSeries A
Role not disclosed